News
Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...
Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...
Development of molecules that target a severe unmet need ...
The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...
With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...
CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...
Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...
Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments ...
Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results